Article info
PDFEditorial commentary
Long-term β interferon in MS: safe, but what effect on disability?
- Correspondence to Professor Neil J Scolding, University of Bristol Institute of Clinical Neurosciences, Department of Neurology, Frenchay Hospital, Bristol BS16 1LE, UK; n.j.scolding{at}bristol.ac.uk
Citation
Long-term β interferon in MS: safe, but what effect on disability?
Publication history
- Received February 24, 2010
- Accepted February 24, 2010
- First published June 22, 2010.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.